Methods for administering weight loss medications

Abstract

Methods and systems for administration of pharmaceuticals using a unit dosage package that includes a first unit dosage that has a first drug and a second drug, a second unit dosage that has the first drug and the second drug, where the second unit dosage includes a different amount of the second drug than the first unit dosage and a unit dosage package is configured to hold the first unit dosage and the second unit dosage. In preferred embodiments the methods and systems are used for administration of weight loss medications.

1 - 30 . (canceled) 
     
     
         31 . A method of providing a pharmaceutical formulation to a patient, said method comprising:
 providing a unit dosage package for a pharmaceutical formulation,   wherein the unit dosage package is configured to hold a first unit dosage and a second unit dosage,   wherein the first unit dosage comprises a first drug and a second drug,   wherein the second unit dosage comprises the first drug and the second drug, and   wherein the second unit dosage comprises a different amount of the second drug than the first unit dosage.   
     
     
         32 . The method of  claim 31  further comprising identifying a patient with an obesity related condition, wherein said obesity-related condition is selected from the group consisting of obesity, hypertension, diabetes, dyslipidaemia, weight gain associated with smoking cessation and weight gain associated with use of a psychotherapeutic drug. 
     
     
         33 . The method of  claim 31 , wherein said second dosage comprises a greater amount of said second drug than said first dosage. 
     
     
         34 . The method of  claim 31 , wherein said first drug or said second drug comprises an antidepressant. 
     
     
         35 . The method of  claim 31 , wherein said first drug or said second drug comprises an anticonvulsant. 
     
     
         36 . The method of  claim 31 , wherein said first drug or said second drug comprises an opioid antagonist. 
     
     
         37 . The method of  claim 31 , wherein said first drug or said second drug comprises an antidiabetic. 
     
     
         38 . The method of  claim 31 , wherein said first drug and said second drug are selected from the group consisting of zonisamide, bupropion, naltrexone, phentermine, topiramate, antidiabetic, olanzapine, fluoxetine, and any combinations, prodrugs or salts thereof. 
     
     
         39 . The method of  claim 31  further comprising identifying the patient as being at risk of suffering an adverse side effect from administration of an anticonvulsant. 
     
     
         40 . The method of  claim 31  further comprising identifying the patient as being at risk of suffering an adverse side effect from administration of an opioid antagonist. 
     
     
         41 . The method of  claim 31  further comprising opening a unit dosage package, the unit dosage package comprising said first dosage and said second dosage. 
     
     
         42 . The method of  claim 31 , wherein said unit dosage package comprises a blister pack. 
     
     
         43 . The method of  claim 31 , wherein the unit dosage package comprises a third unit dosage and, wherein said third dosage comprises a greater amount of said second drug than said second dosage. 
     
     
         44 . The method of  claim 31 , wherein providing the unit dosage package comprises removing said first dosage and said second dosage from the unit dosage package. 
     
     
         45 . The method of  claim 31 , wherein providing a unit dosage package comprises administering a tablet that comprises said first drug and said second drug to said patient, wherein the tablet comprises a plurality of layers. 
     
     
         46 . The method of  claim 45 , wherein said tablet is a trilayer tablet.